Cathay Biotech Inc. (SHA:688065)
41.42
-1.00 (-2.36%)
Sep 4, 2026, 3:00 PM CST
Cathay Biotech Market Cap
Cathay Biotech has a market cap or net worth of 29.85 billion as of September 4, 2026. Its market cap has decreased by -20.04% in one year.
Market Cap
29.85B
Enterprise Value
25.09B
Revenue
3.52B
Ranking
n/a
PE Ratio
47.32
Stock Price
41.42
ChartMarket Cap Chart
Since August 12, 2020, Cathay Biotech's market cap has decreased from 65.42B to 29.85B, a decrease of -54.37%. That is a compound annual growth rate of -12.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 29.85B | -16.83% |
| Dec 31, 2025 | 35.89B | 59.12% |
| Dec 31, 2024 | 22.56B | -29.54% |
| Dec 29, 2023 | 32.01B | -10.45% |
| Dec 30, 2022 | 35.75B | -53.44% |
| Dec 31, 2021 | 76.79B | 116.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inner Mongolia Junzheng Energy & Chemical Group | 40.25B |
| Do-Fluoride New Materials | 40.09B |
| Hoshine Silicon Industry | 39.27B |
| Hubei Xingfa Chemicals Group | 36.88B |
| Jiangsu Boqian New Materials Stock | 36.57B |
| Zhejiang Sanmei Chemical Industry | 35.93B |
| Xinfengming Group | 33.35B |
| Jinan Shengquan Group Share Holding | 32.38B |